To The Moon

Daily Options for Consistent Income Until Assigned Trading options can be risky, but when approached with discipline and cash management, it becomes a strategic income-generating machine. One method I use actively is swing trading short-dated cash-secured puts (CSPs) on IWM, the iShares Russell 2000 ETF. This strategy has allowed me to earn consistent income, take advantage of high premiums, and manage risk through daily adjustments. Here’s a deeper dive into what CSPs are, how short-dated puts work, and how I execute my daily swing trades using IWM puts. ⸻ 💡 What is a Cash-Secured Put? A cash-secured put is a conservative options strategy in which I sell a put option while holding enough cash to buy the underlying shares if assigned. For example, selling one IWM put contract at a $221 str

$Hims & Hers Health Inc.(HIMS)$    Here’s a fundamental analysis of Hims & Hers Health, Inc. (Ticker: HIMS), tailored for a retail investor who wants a clear understanding of its business, financials, and investment potential. ⸻ 📊 Fundamental Analysis of Hims & Hers Health, Inc. (HIMS) 💼 Company Overview Hims & Hers Health, Inc. is a telehealth and wellness company focused on providing personalized healthcare solutions directly to consumers. The platform covers a range of services from sexual health, mental health, dermatology, hair care, to primary care, largely through online consultations and product subscriptions. Founded in 2017 and going public via a SPAC in 2021, HIMS has aimed to di

$Zepp Health Corporation(ZEPP)$ The Shockwave in the Wearables Market On the morning of its Q2 2025 earnings release, Zepp Health Corporation (NYSE: ZEPP) ignited one of the most astonishing price surges in recent market memory. In just hours, shares rocketed more than 2,200% from pre-earnings levels, shattering resistance levels, igniting social media chatter, and triggering circuit breakers. What began as a fundamental earnings beat snowballed into a full-blown speculative mania. For long-time observers of the wearables market, Zepp Health—known for its Amazfit and Zepp-branded smartwatches—has had a turbulent public history. Since its days as Huami Corporation, a Xiaomi ecosystem partner, the company has battled intense competition from Apple,

$Walt Disney(DIS)$ I’ve made an additional investment in Disney stock, driven by its bold expansion into immersive, franchise-collapsing digital storytelling. Historically, Disney fiercely protected its character IP boundaries, but its collaboration with Epic Games and plans for its own Fortnite-style universe (code-named “Bulldog”) signal a strategic shift. By uniting Marvel, Star Wars, Avatar, and classic Disney characters in an interactive gaming world, Disney is targeting next-gen fandom and monetization opportunities across media and merchandise. This pivot could unlock new revenue streams and reignite investor confidence in Disney’s creative moat.

$Upbound Group(UPBD)$ UPBD: bought another batch of UPBD to accumulate a long position on this stock. As of now, I'm in paper loss of about 12% after a large 15% drop on earnings last Thurs 31st July. UPBD actually had earning and revenue beat but still suffer the sell off. If I was comfortable buying before earning at higher price, the earnings only to confirm my conviction.  Separately I've also sold a cash secured put at strike $25 to accumulate more of the price drop to that level so those will likely get exercised as well when due.  I'll just continue to accumulate few more batches till full allocation and stay put. Valuation is undemanding at current price across few valuation methods and I'll probably accumulate and wait for

$nCino(NCNO)$ NCNO: bought another batch of small positions on this small financial software company. Stock had been running higher since 2nd April and continue to run up healthy after periods of consolidation. It's on the verge of breakout of the 200 days MA at $31.10 on 21st July on to get rejected and accumulated 8 consecutive red daily candles before turning on 4th Aug.  i've accumulated sufficient position in this counter so will hold off for now until better results.  As of now, I'm 6.7% in the red for this trade.

$Palantir Technologies Inc.(PLTR)$ PLTR: shorter some PLTR after the closing at $162.50.  Rookie mistake on my part and I would still like to share it.  The short was initiated few weeks ago and was queued as 'GTC' good till cancelled. It didn't hit the required $162.5 price so the queue was still open.  I missed out the earnings was after the close 4th Aug and PLTR rose higher on good earnings and revenues.  At some point will look to close the short and call it a day as I'm technically long term bullish on PLTR but played short term overbought trades that didn't work based on latest outcome. 

$TCH.HK 20250929 570.00 CALL$ SEPT strangle . 40$ spread, total premiums $30.05. Break even range : $516.69- $586.74

$AMZN 20250822 200.0 PUT$ AMZN: collect $135 (0.65%) premium on this cash secured put with strike at $200. Contract expires in 3 weeks on 22nd Aug. Sold with intend to accumulate shares so the strike was lower and premium wasn't great.  AMZN sold down 8.27% on earning last Fri along with bearish market and now closed at $211.65.  At $200 or below, I'll be happy to start accumulating positions so the sold puts starts as early trades to reach that level.  Even if it didn't drop that low, happy to just collect premiums along the way. 

$RCAT 20250919 8.0 CALL$   rcats is real deal.

$Figma(FIG)$ Based on the most recent market coverage: 📉 Figma's Valuation & Recent Price Action Figma (NYSE: FIG) soared roughly 250–270% during its IPO debut, jumping from an initial price of $33 to highs above $140 within a few sessions . But a swift 23–27% pullback followed, bringing the share price down into the $90–95 range as early investors took profits . Analysts remain cautious: even after the dip, Figma still trades at a forward P/S ratio of 60–94×, compared to Adobe’s ~11×, raising questions about the sustainability of its lofty valuation . --- 🧐 Will Figma Really Drop to $50 or Below? A drop to $50 or below—a decline of nearly 50%+ from current levels—would represent unprecedented mean reversion for a stock still early in public t

🟩 📉 **STI Drops 1.4% Amid Global Sell-Off 🌏** Join Iggy as he breaks down the Straits Times Index's latest 1.4% dip amidst global market turbulence, shedding light on the key factors driving this shift. From Wall Street's recession fears to Singapore's banking sector taking a hit, this episode is packed with insights to help you navigate the financial storm and make smarter investment decisions. 💡 **Spotlight on SGX Movers** Swipe through today’s must-know stories: - 🏢 CICT's bold $600M capital raise and strategic purchase of CapitaSpring. - 🌏 Keppel's updated Vietnam deal and its impact on shareholder returns. - ✈️ SATS’ game-changing cargo facility at Changi, cutting handling times by 20%. - 🥤 F&N's latest earnings and how it stands resilient amid regional challenges. - 🌱 MPact’s $20

I'm currently most bullish on $DBS Group Holdings(D05.SI)$ due to its strong Q1 showing and ability to maintain NIM above 2% despite industry pressure. Its record-high fee income and treasury sales show strong diversification beyond interest income, while a solid cost-to-income ratio supports sustained performance. The bank's share price has also outperformed peers this year, reflecting market confidence. UOB’s $UOB(U11.SI)$ weaker stock performance could be a long-term opportunity. Despite lower net interest income, its non-interest income segments like wealth management and trading showed strong growth. Its consistent dividend payout also adds to its appeal for income-focused investors. The key

Palantir Technologies Inc. (PLTR) recently hit a new all-time high of $176.33 on August 5, 2025, driven by a stellar Q2 2025 earnings report. The company reported a record $1 billion in quarterly revenue, up 48% year-over-year, with adjusted EPS of $0.16, beating estimates of $0.14. U.S. commercial revenue surged 93% to $306 million, and U.S. government revenue grew 53% to $426 million. Palantir also raised its full-year revenue guidance to $4.142–$4.150 billion, signaling confidence in continued growth. The stock surged 6.9%–9.8% in trading sessions following the report, reflecting strong market enthusiasm. Reasons to HoldStrong Growth Momentum: Palantir’s revenue growth, particularly in AI-driven solutions, is robust. The company’s U.S. commercial customer count grew 64% year-over-year,